Royal Bank Of Canada Vivos Therapeutics, Inc. Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.18 - $0.52 $162 - $468	-900 Reduced 67.21%	439 $0
Q2 2023 Aug 14, 2023	BUY	$0.31 - $0.55 $312 - $553	1,007 Added 303.31%	1,339 $0
Q1 2023 May 15, 2023	BUY	$0.32 - $1.88 $74 - $436	232 Added 232.0%	332 $0
Q4 2022 Feb 14, 2023	SELL	$0.35 - $20.75 $5,972 - $354,098	-17,065 Reduced 99.42%	100 $0
Q3 2022 Nov 14, 2022	BUY	$0.83 - $21.25 $14,046 - $359,635	16,924 Added 7022.41%	17,165 $11,000
Q2 2022 Aug 15, 2022	BUY	$1.12 - $2.18 $112 - $218	100 Added 70.92%	241 $0
Q4 2021 Feb 14, 2022	SELL	$2.25 - $4.11 $1,208 - $2,207	-537 Reduced 79.2%	141 $0
Q3 2021 Nov 15, 2021	BUY	$2.71 - $5.9 $1,837 - $4,000	678 New	678 $3,000

Ticker VVOS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 23,012,100
Market Cap $60.3M
Description
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.